Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease

NCT03119636 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER_GOV

Sponsor class

Conditions

Parkinson's Disease

Interventions

BIOLOGICAL: NPC transplantation
DRUG: Levodopa

Sponsor

Chinese Academy of Sciences

Collaborators

[object Object]